berberine has been researched along with Benign Neoplasms, Brain in 14 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was aimed to investigate the effect of berberine on cell migration and invasion in human retinoblastoma (Rb) cells." | 7.88 | Inhibition of migration and invasion by berberine via inactivation of PI3K/Akt and p38 in human retinoblastoma cell line. ( Chen, K; Gong, Y; Gui, M; Guo, X; Jin, Y; Ma, R; Wang, P; Wang, X; Wang, Y; Wu, Y; Yang, L; Yuan, J; Zhong, Y, 2018) |
| "Berberine is a protoberberine alkaloid with wide range of pharmacological activities, applicable to various pathological conditions." | 6.72 | Therapeutic Potential of Berberine in the Treatment of Glioma: Insights into Its Regulatory Mechanisms. ( Asemi, Z; Behnam, M; Mirzaei, H; Pourattar, MA; Razavi, ZS; Tamtaji, OR, 2021) |
| "Berberine (BBR) is an isoquinoline quaternary alkaloid extracted from a variety of medicinal plants." | 6.66 | Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression. ( Bruno, G; Calvani, M; Favre, C; Subbiani, A, 2020) |
| "Chemotherapy is a conventional treatment for glioma, but its efficacy is greatly limited due to low blood-brain barrier (BBB) permeability and lack of specificity." | 5.72 | Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma. ( Chen, J; Hai, L; Liu, Q; Lu, R; Wang, S; Wu, Y; Yang, C; Yang, Z, 2022) |
| "Berberine (BBR) was the potential drug for anti-tumor in glioma cells." | 5.56 | Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial Pathway. ( An, J; Dong, W; He, Y; Jia, X; Jia, Y; Liu, K; Ma, X; Pan, Y; Sheng, J; Wang, B; Wang, J; Wang, S; Wang, X; Wu, Y; Yu, D; Yu, W; Zhao, Y; Zhu, W, 2020) |
| " However, use of a formulation of curcumin with higher bioavailability or combining it with berberine as a co-treatment may be proving to be more efficacious against cancer." | 5.51 | Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments. ( Dunbar, GL; Maiti, P; Plemmons, A, 2019) |
| "Berberine treatment of T98G cell lines inhibited cell proliferation and induced cell death in a dose (50-200 microg/ml) dependent manner with an IC50 value of 134 microg/ml, which was associated with an increase in G1 arrest." | 5.35 | Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway. ( Eom, KS; Hong, JM; Kim, JM; Kim, TY; Park, R; So, HS; Youn, MJ, 2008) |
| "This study was aimed to investigate the effect of berberine on cell migration and invasion in human retinoblastoma (Rb) cells." | 3.88 | Inhibition of migration and invasion by berberine via inactivation of PI3K/Akt and p38 in human retinoblastoma cell line. ( Chen, K; Gong, Y; Gui, M; Guo, X; Jin, Y; Ma, R; Wang, P; Wang, X; Wang, Y; Wu, Y; Yang, L; Yuan, J; Zhong, Y, 2018) |
| "Berberine is a protoberberine alkaloid with wide range of pharmacological activities, applicable to various pathological conditions." | 2.72 | Therapeutic Potential of Berberine in the Treatment of Glioma: Insights into Its Regulatory Mechanisms. ( Asemi, Z; Behnam, M; Mirzaei, H; Pourattar, MA; Razavi, ZS; Tamtaji, OR, 2021) |
| "Berberine (BBR) is an isoquinoline quaternary alkaloid extracted from a variety of medicinal plants." | 2.66 | Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression. ( Bruno, G; Calvani, M; Favre, C; Subbiani, A, 2020) |
| "Chemotherapy is a conventional treatment for glioma, but its efficacy is greatly limited due to low blood-brain barrier (BBB) permeability and lack of specificity." | 1.72 | Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma. ( Chen, J; Hai, L; Liu, Q; Lu, R; Wang, S; Wu, Y; Yang, C; Yang, Z, 2022) |
| "Berberine (BBR) was the potential drug for anti-tumor in glioma cells." | 1.56 | Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial Pathway. ( An, J; Dong, W; He, Y; Jia, X; Jia, Y; Liu, K; Ma, X; Pan, Y; Sheng, J; Wang, B; Wang, J; Wang, S; Wang, X; Wu, Y; Yu, D; Yu, W; Zhao, Y; Zhu, W, 2020) |
| " However, use of a formulation of curcumin with higher bioavailability or combining it with berberine as a co-treatment may be proving to be more efficacious against cancer." | 1.51 | Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments. ( Dunbar, GL; Maiti, P; Plemmons, A, 2019) |
| "Berberine treatment of T98G cell lines inhibited cell proliferation and induced cell death in a dose (50-200 microg/ml) dependent manner with an IC50 value of 134 microg/ml, which was associated with an increase in G1 arrest." | 1.35 | Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway. ( Eom, KS; Hong, JM; Kim, JM; Kim, TY; Park, R; So, HS; Youn, MJ, 2008) |
| "The cell-killing effect and its possible mechanism of berberine used alone or in combination with argon ion laser treatment on 9L rat glioma cells were studied." | 1.29 | Effect of berberine alone or in combination with argon ion laser treatment on 9L rat glioma cell line. ( Chen, KT; Chen, YC; Hao, DM; Liu, ZX; You, ZS, 1994) |
| "Berberine was evaluated for antitumor activity against malignant brain tumors." | 1.28 | Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors. ( Dougherty, DV; Rosenblum, ML; Zhang, RX, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Bibak, B | 1 |
| Shakeri, F | 1 |
| Keshavarzi, Z | 1 |
| Mollazadeh, H | 1 |
| Javid, H | 1 |
| Jalili-Nik, M | 1 |
| Sathyapalan, T | 1 |
| Afshari, AR | 1 |
| Sahebkar, A | 1 |
| Yang, C | 1 |
| Yang, Z | 1 |
| Wang, S | 2 |
| Chen, J | 1 |
| Liu, Q | 1 |
| Hai, L | 1 |
| Lu, R | 1 |
| Wu, Y | 3 |
| Maiti, P | 1 |
| Plemmons, A | 1 |
| Dunbar, GL | 1 |
| Asemi, Z | 1 |
| Behnam, M | 1 |
| Pourattar, MA | 1 |
| Mirzaei, H | 1 |
| Razavi, ZS | 1 |
| Tamtaji, OR | 1 |
| Calvani, M | 1 |
| Subbiani, A | 1 |
| Bruno, G | 1 |
| Favre, C | 1 |
| An, J | 1 |
| Dong, W | 1 |
| Wang, X | 2 |
| Sheng, J | 1 |
| Jia, Y | 1 |
| He, Y | 2 |
| Ma, X | 1 |
| Wang, J | 1 |
| Yu, D | 1 |
| Jia, X | 1 |
| Wang, B | 1 |
| Yu, W | 1 |
| Liu, K | 1 |
| Zhao, Y | 1 |
| Zhu, W | 1 |
| Pan, Y | 1 |
| Sun, Y | 1 |
| Yu, J | 1 |
| Liu, X | 2 |
| Zhang, C | 1 |
| Cao, J | 1 |
| Li, G | 1 |
| Chen, Y | 1 |
| Huang, H | 1 |
| Wang, Y | 1 |
| Yuan, J | 1 |
| Yang, L | 1 |
| Wang, P | 1 |
| Chen, K | 1 |
| Ma, R | 1 |
| Zhong, Y | 1 |
| Guo, X | 1 |
| Gong, Y | 1 |
| Gui, M | 1 |
| Jin, Y | 1 |
| Wang, DY | 1 |
| Yeh, CC | 1 |
| Lee, JH | 1 |
| Hung, CF | 1 |
| Chung, JG | 1 |
| Liu, SJ | 1 |
| Sun, YM | 1 |
| Tian, DF | 1 |
| He, YC | 1 |
| Zeng, L | 1 |
| Ling, CQ | 1 |
| Sun, SH | 1 |
| Eom, KS | 1 |
| Hong, JM | 1 |
| Youn, MJ | 1 |
| So, HS | 1 |
| Park, R | 1 |
| Kim, JM | 1 |
| Kim, TY | 1 |
| Chen, KT | 1 |
| Hao, DM | 1 |
| Liu, ZX | 1 |
| Chen, YC | 1 |
| You, ZS | 1 |
| Iwasa, K | 1 |
| Moriyasu, M | 1 |
| Yamori, T | 1 |
| Turuo, T | 1 |
| Lee, DU | 1 |
| Wiegrebe, W | 1 |
| Zhang, RX | 1 |
| Dougherty, DV | 1 |
| Rosenblum, ML | 1 |
3 reviews available for berberine and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy.
Topics: Apoptosis; Berberine; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioblastoma; Humans | 2022 |
Therapeutic Potential of Berberine in the Treatment of Glioma: Insights into Its Regulatory Mechanisms.
Topics: Animals; Antineoplastic Agents, Phytogenic; Autophagy; Berberine; Brain Neoplasms; Cell Proliferatio | 2021 |
Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression.
Topics: Adrenergic beta-Antagonists; Animals; Berberine; Brain Neoplasms; Cell Proliferation; Dietary Supple | 2020 |
11 other studies available for berberine and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma.
Topics: Berberine; Brain Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Folic Acid; Glioma; Humans; Hyd | 2022 |
Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Berberine; Biological Availability; Brain | 2019 |
Glucose-coated Berberine Nanodrug for Glioma Therapy through Mitochondrial Pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Berberine; Biological Transport; Blood-Brain Barrier; Bra | 2020 |
Oncosis-like cell death is induced by berberine through ERK1/2-mediated impairment of mitochondrial aerobic respiration in gliomas.
Topics: Adenosine Triphosphate; Aerobiosis; Animals; Apoptosis; Autophagy; Berberine; Brain Neoplasms; Cell | 2018 |
Inhibition of migration and invasion by berberine via inactivation of PI3K/Akt and p38 in human retinoblastoma cell line.
Topics: Berberine; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Huma | 2018 |
Berberine inhibited arylamine N-acetyltransferase activity and gene expression and DNA adduct formation in human malignant astrocytoma (G9T/VGH) and brain glioblastoma multiforms (GBM 8401) cells.
Topics: Arylamine N-Acetyltransferase; Astrocytoma; Base Sequence; Berberine; Brain Neoplasms; DNA Adducts; | 2002 |
Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma.
Topics: Adult; Animals; Antineoplastic Agents; Berberine; Brain Neoplasms; Carcinoma; Down-Regulation; Drug | 2008 |
Berberine induces G1 arrest and apoptosis in human glioblastoma T98G cells through mitochondrial/caspases pathway.
Topics: Apoptosis; Berberine; Blotting, Western; Brain Neoplasms; Caspases; Cell Cycle; Cell Cycle Proteins; | 2008 |
Effect of berberine alone or in combination with argon ion laser treatment on 9L rat glioma cell line.
Topics: Animals; Antineoplastic Agents; Berberine; Brain Neoplasms; Cell Survival; Gliosarcoma; Laser Therap | 1994 |
In vitro cytotoxicity of the protoberberine-type alkaloids.
Topics: Animals; Antineoplastic Agents, Phytogenic; Berberine; Berberine Alkaloids; Brain Neoplasms; Breast | 2001 |
Laboratory studies of berberine used alone and in combination with 1,3-bis(2-chloroethyl)-1-nitrosourea to treat malignant brain tumors.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Berberine; Brain Neo | 1990 |